ArticleBiology of sport2025
Global burden of chronic kidney disease due to diabetes mellitus type 2 attributable to low physical activity and high body mass index from 1990 to 2021.
Article in Biology of sport, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study aimed to assess the global chronic kidney disease due to diabetes mellitus type 2 (CKD-T2DM) attributable to low physical activity (PA) and high body-mass index (BMI). Data on CKD-T2DM deaths, disability-adjusted life years (DALYs), and risk factor exposure were obtained from the Global Burden of Disease Study 2021. The jointpoint model was used to detect the temporal patterns throughout the past 32 years, and the age-period-cohort analyses were preformed to clarify the trends in epidemiological shift. The global age-standardized rate (ASR) of DALYs for CKD-T2DM linked to low PA were 8.19 (95% UI, 3.21 to 13.60) per 100,000 people. No significant percent changes were observed since 1990. Globally, high BMI accounted for 50.14 (95% UI, 22.56 to 79.15) ASR of DALYs with a marked increase of 62.66 %(95 % UI, 44.24 to 78.73) from 1990. Both low PA and high BMI-attributable CKD-T2DM showed a surging trend in population aged less than 40 or greater than 75. There were consistent nonlinear trajectories between socio-demographic index (SDI) and CKD-T2DM attributable to low PA and high BMI, which reached a peak at SDI = 0.6 before decreasing with a higher SDI value. Globally, there are rising trends in CKD-T2DM burden, low PA exposure, and high BMI exposure until 2050. There are secular improvements in CKD-T2DM attributable to low PA, while it remains a severe challenge in that of high BMI. Considerable temporal and regional variation highlight the urgency of structural, context-specific strategies targeted on modifiable factors to tackle the CKD-T2DM burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.